Literature DB >> 17188755

The inflammatory response in stroke.

Qing Wang1, Xian Nan Tang, Midori A Yenari.   

Abstract

Recent works in the area of stroke and brain ischemia has demonstrated the significance of the inflammatory response accompanying necrotic brain injury. Acutely, this response appears to contribute to ischemic pathology, and anti-inflammatory strategies have become popular. This chapter will discuss the current knowledge of the contribution of systemic and local inflammation in experimental stroke. It will review the role of specific cell types including leukocytes, endothelium, glia, microglia, the extracellular matrix and neurons. Intracellular inflammatory signaling pathways such as nuclear factor kappa beta and mitogen-activated protein kinases, and mediators produced by inflammatory cells such as cytokines, chemokines, reactive oxygen species and arachidonic acid metabolites will be reviewed as well as the potential for therapy in stroke and hypoxic-ischemic injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188755      PMCID: PMC1868538          DOI: 10.1016/j.jneuroim.2006.11.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  212 in total

Review 1.  Immune function of astrocytes.

Authors:  Y Dong; E N Benveniste
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

Review 2.  Role of nuclear factor kappa B in neuropathological mechanisms.

Authors:  D F Cechetto
Journal:  Prog Brain Res       Date:  2001       Impact factor: 2.453

3.  Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain.

Authors:  Shunya Takizawa; Yasuaki Aratani; Naoto Fukuyama; Nobuyo Maeda; Hisayuki Hirabayashi; Hideki Koyama; Yukito Shinohara; Hiroe Nakazawa
Journal:  J Cereb Blood Flow Metab       Date:  2002-01       Impact factor: 6.200

4.  Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice.

Authors:  C Iadecola; K Sugimoto; K Niwa; K Kazama; M E Ross
Journal:  J Cereb Blood Flow Metab       Date:  2001-12       Impact factor: 6.200

5.  The NF-kappaB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia.

Authors:  W D Hill; D C Hess; J E Carroll; C G Wakade; E F Howard; Q Chen; C Cheng; A Martin-Studdard; J L Waller; R A Beswick
Journal:  Brain Res Bull       Date:  2001-06       Impact factor: 4.077

6.  Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke.

Authors:  T Sairanen; O Carpén; M L Karjalainen-Lindsberg; A Paetau; U Turpeinen; M Kaste; P J Lindsberg
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

7.  Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia.

Authors:  C Iadecola; C Forster; S Nogawa; H B Clark; M E Ross
Journal:  Acta Neuropathol       Date:  1999-07       Impact factor: 17.088

8.  Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial.

Authors: 
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

9.  Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest.

Authors:  T Ueno; Y Sawa; S Kitagawa-Sakakida; M Nishimura; R Morishita; Y Kaneda; E Kohmura; T Yoshimine; H Matsuda
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

Review 10.  Cytokines and acute neurodegeneration.

Authors:  S M Allan; N J Rothwell
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

View more
  466 in total

1.  Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome.

Authors:  Amjad Shehadah; Jieli Chen; Xu Cui; Cynthia Roberts; Mei Lu; Michael Chopp
Journal:  J Neurol Sci       Date:  2010-05-07       Impact factor: 3.181

2.  Preconditioning with a novel metallopharmaceutical NO donor in anesthetized rats subjected to brain ischemia/reperfusion.

Authors:  Marcio Wilker Soares Campelo; Reinaldo Barreto Oriá; Luiz Gonzaga de França Lopes; Gerly Anne de Castro Brito; Armenio Aguiar dos Santos; Raquel Cavalcante de Vasconcelos; Francisco Ordelei Nascimento da Silva; Beatrice Nuto Nobrega; Moisés Tolentino Bento-Silva; Paulo Roberto Leitão de Vasconcelos
Journal:  Neurochem Res       Date:  2011-12-10       Impact factor: 3.996

3.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

4.  Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain.

Authors:  Danica Petrovic-Djergovic; Matthew C Hyman; Jessica J Ray; Diane Bouis; Scott H Visovatti; Takanori Hayasaki; David J Pinsky
Journal:  J Immunol       Date:  2012-01-30       Impact factor: 5.422

Review 5.  MicroRNAs regulate the chaperone network in cerebral ischemia.

Authors:  Yi-Bing Ouyang; Rona G Giffard
Journal:  Transl Stroke Res       Date:  2013-08-17       Impact factor: 6.829

Review 6.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

7.  Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats.

Authors:  Huong L Moldthan; Aaron C Hirko; Jeffrey S Thinschmidt; Maria B Grant; Zhimin Li; Joanna Peris; Yuanqing Lu; Ahmed S Elshikha; Michael A King; Jeffrey A Hughes; Sihong Song
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-02-28       Impact factor: 2.136

8.  Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia.

Authors:  Tamer Altay; Bethann McLaughlin; Jane Y Wu; T S Park; Jeffrey M Gidday
Journal:  Exp Neurol       Date:  2007-07-26       Impact factor: 5.330

Review 9.  Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

Authors:  Kota Kurisu; Jong Youl Kim; Jesung You; Midori A Yenari
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

10.  Middle Cerebral Artery Occlusion Model of Stroke in Rodents: A Step-by-Step Approach.

Authors:  Shima Shahjouei; Peter Y Cai; Saeed Ansari; Sharareh Sharififar; Hassan Azari; Sarah Ganji; Ramin Zand
Journal:  J Vasc Interv Neurol       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.